Impact of Xerostomia on Oral Microbiome and Mucosal Integrity

Authors

  • Dr. Fouzia Tabassum Department of Dentistry, Ayub Medical College Abbottabad, Pakistan.
  • Dr. Sana Jalil Hasan Associate Professor Operative Dentistry and Endodontics, Margalla Institute of Health Sciences, Rawalpindi, Pakistan.
  • Dr. Abdul Manan Shahid Associate Professor/HOD, Oral Medicine and Diagnostics, Islamic International Dental College/Hospital, Islamabad, Pakistan.
  • Dr. Salwan Ghani BDS, M.Sc (UK), MFDS RCS(Eng), PGDip (Riphah), CHPE, Assistant Professor, HoD Oral Biology, Riphah International University Islamabad, Islamic International Dental College Islamabad, Pakistan.
  • Dr. Faisal Shafiq Malik Department of Community Dentistry, Islamic International Dental College, Islamabad, Pakistan.
  • Dr. Sara Gardezi Assistant Professor, Department of Oral Biology, Altamash Institute of Dental Medicine, Karachi, Pakistan.

Keywords:

Xerostomia, Oral microbiome, Dysbiosis, Oral mucosa, Salivary flow, Candida

Abstract

Background: Xerostomia diminishes oral mucosal protection by saliva, and may also alter the oral microbial balance and integrity of oral mucosa; the relationship between xerostomia and dysbiosis and oral mucosal health is not fully understood.

Objective: To determine the correlation between xerostomia, changes in the oral microbiome, and changes in the integrity of the oral mucosa.

Methods: This is an analytical cross sectional study that was carried out in the department of oral medicine and oral and maxillofacial surgery of tertiary care dental hospital in Pakistan between December 2025 and May 2026. Patients with xerostomia (n = 50) and age and sex-matched controls (n = 50) were enrolled using consecutive sampling. Salivary flow rates, clinical mucosal examination and microbiological profiles were evaluated and compared between the groups.

Results: Mean age was 48.6 ± 12.4 years and ages and sex distributions were comparable between groups. Salivary flow was markedly lower in the xerostomia group (0.18 ± 0.07 vs 0.43 ± 0.11 mL/min, p < 0.001). Erythema (54.0% vs 16.0%), fissuring (42.0% vs 10.0%), and ulceration (28.0% vs 6.0%) were more frequent among patients with xerostomia. Candida species were detected in 36.0% of patients versus 10.0% of controls, and overall microbiome alteration occurred in 74.0% versus 28.0% (OR 7.32, 95% CI 3.03 to 17.71, p < 0.001).

Conclusion: There was a significant relationship between xerostomia and the alteration of oral microorganisms and damage to the oral mucosa. It is essential to maintain the function and microbial balance of the salivary organs and early clinical diagnosis could be helpful in avoiding the occurrence of mucosal complications.

References

Pei XM, Zhou LX, Tsang MW, Tai WC, Wong SC. The oral microbial ecosystem in age-related xerostomia: a critical review. International journal of molecular sciences. 2024 Nov 28;25(23):12815.

Weng CT, Huang SL, Yang HW, Kao CC, Wei CC, Huang YF. Oral microbiota in xerostomia patients-A preliminary study. Journal of Dental Sciences. 2022 Jan 1;17(1):324-30.

Park Y. Xerostomia and its impact on oral health. InSalivary Analysis-Biomarkers, Clinical Applications, and Emerging Technologies 2025 May 12. IntechOpen.

Bogdan-Andreescu CF, Bănățeanu AM, Albu CC, Poalelungi CV, Botoacă O, Damian CM, Dȋră LM, Albu ŞD, Brăila MG, Cadar E, Brăila AD. Oral mycobiome alterations in postmenopausal women: Links to inflammation, xerostomia, and systemic health. Biomedicines. 2024 Nov 9;12(11):2569.

Rajasekaran JJ, Krishnamurthy HK, Bosco J, Jayaraman V, Krishna K, Wang T, Bei K. Oral microbiome: a review of its impact on oral and systemic health. Microorganisms. 2024 Aug 29;12(9):1797.

Witwit LJ, Jasim AI, Jassim SD. Xerostomia And Its Effect On Oral Microbial Growth: An Overview. Journal of University of Babylon for Pure and Applied Sciences. 2025 Dec 31;33(4):471-84.

Mougeot JL, Beckman MF, Henry AA, Lalla RV, Brennan MT, Mougeot FB. Oral dryness related symptoms in radiation-treated head and neck cancer patients: a pilot study of oral microbiome composition and function. BMC microbiology. 2026 Mar 4;26(1):334.

Gonzalez Agurto M, Olivares N, Canedo-Marroquin G, Espinoza D, Tortora SC. The intersection of the oral microbiome and salivary metabolites in head and neck cancer: from diagnosis to treatment. Cancers. 2024 Oct 21;16(20):3545.

Muszyński D, Kucharski R, Marek-Trzonkowska N, Kalinowska M, Brzoska A, Bolcewicz M, Kalinowski L, Kaźmierczak-Siedlecka K. Treatment of xerostomia in Sjögren’s syndrome–what effect does it have on the oral microbiome?. Frontiers in cellular and infection microbiology. 2025 Apr 14;15:1484951.

Poudel S, Kafle P, Pandey P, Thapa P, Baral A, Ghimire S, Subedi B. Impact of Xerostomia on dental treatment outcomes: a systematic review. BMC Oral Health. 2026 Feb 2;26(1):429.

Maita K, Fujihara H, Matsumura M, Miyakawa M, Baba R, Morimoto H, Nakayama R, Ito Y, Kawaguchi K, Hamada Y. Impact of Reduced Saliva Production on Intestinal Integrity and Microbiome Alterations: A Sialoadenectomy Mouse Model Study. International Journal of Molecular Sciences. 2024 Nov 20;25(22):12455.

Reza N, Qader OA, Al-Rawas M, Omar M, Abdullah JY, Urmi SY. Enzyme-Based Mouthwashes for Oral Wound Healing and Xerostomia. European Journal of Dentistry. 2026 Jul 8.

Lin B, Zhao F, Liu Y, Sun J, Feng J, Zhao L, Wang H, Chen H, Yan W, Guo X, Shi S. Alterations in oral microbiota of differentiated thyroid carcinoma patients with xerostomia after radioiodine therapy. Frontiers in endocrinology. 2022 Aug 26;13:895970.

Kucharski R, Sobocki BK, Stachowska E, Bulman N, Kalinowski L, Kaźmierczak-Siedlecka K. Dental problems and oral microbiome alterations in ulcerative colitis. Frontiers in immunology. 2025 Feb 5;16:1502605.

Taburee W, Jobsri J, Samnieng P. Development and evaluation of a novel artificial saliva for xerostomia: physicochemical, microbial, and safety profiles. BMC Oral Health. 2026 Sep 23.

Khanna V, Kumar S, Kumar S, Verma S, Grigoriadis A, Kumar A. The gut microbiome in oral health and disease: evidence toward bidirectional oral-gut axis communication. Frontiers in Microbiology. 2026 Jun 9;17:1817689.

Faruque M, Wanschers M, Ligtenberg AJ, Laine ML, Bikker FJ. A review on the role of salivary MUC5B in oral health. Journal of Oral Biosciences. 2022 Dec 1;64(4):392-9.

Abdelbary MM, Hatting M, Bott A, Dahlhausen A, Keller D, Trautwein C, Conrads G. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease. Frontiers in Cellular and Infection Microbiology. 2022 Oct 7;12:1010853.

Downloads

Published

2026-11-13

How to Cite

Dr. Fouzia Tabassum, Dr. Sana Jalil Hasan, Dr. Abdul Manan Shahid, Dr. Salwan Ghani, Dr. Faisal Shafiq Malik, & Dr. Sara Gardezi. (2026). Impact of Xerostomia on Oral Microbiome and Mucosal Integrity. International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 8031–8039. Retrieved from https://www.ijprt.org/index.php/pub/article/view/3591

Issue

Section

Research Article